Next Century Growth Investors Has Lowered Edwards Lifesciences (EW) Holding; Vesta Insurance Group (VTA)’s Sentiment Is 1.48

November 15, 2017 - By Maria Brooks

Invesco Dynamic Credit Opportunities Fund is a diversified closed-end management investment company. The company has market cap of $839.49 million. The Fund’s investment objective is to seek a high level of current income, with a secondary objective of capital appreciation. It currently has negative earnings. The Fund invests primarily in a portfolio of interests in floating or variable senior loans to firms, partnerships and other entities, which operate in a range of industries and geographic regions.

Next Century Growth Investors Llc decreased Edwards Lifesciences Corp (EW) stake by 22.61% reported in 2017Q2 SEC filing. Next Century Growth Investors Llc sold 8,957 shares as Edwards Lifesciences Corp (EW)’s stock rose 25.80%. The Next Century Growth Investors Llc holds 30,650 shares with $3.62M value, down from 39,607 last quarter. Edwards Lifesciences Corp now has $22.16 billion valuation. The stock declined 0.43% or $0.45 reaching $104.7 per share. About 5,167 shares traded. Edwards Lifesciences Corp (NYSE:EW) has risen 15.41% since November 15, 2016 and is uptrending. It has underperformed by 1.29% the S&P500.

Analysts await Edwards Lifesciences Corp (NYSE:EW) to report earnings on February, 7. They expect $0.90 EPS, up 20.00% or $0.15 from last year’s $0.75 per share. EW’s profit will be $190.49M for 29.08 P/E if the $0.90 EPS becomes a reality. After $0.84 actual EPS reported by Edwards Lifesciences Corp for the previous quarter, Wall Street now forecasts 7.14% EPS growth.

Next Century Growth Investors Llc increased Neogenomics Inc (NASDAQ:NEO) stake by 456,408 shares to 2.54M valued at $22.74M in 2017Q2. It also upped Irhythm Technologies stake by 394,847 shares and now owns 563,870 shares. Coherent Inc. (NASDAQ:COHR) was raised too.

Among 27 analysts covering Edwards Lifesciences Corp (NYSE:EW), 20 have Buy rating, 1 Sell and 6 Hold. Therefore 74% are positive. Edwards Lifesciences Corp had 84 analyst reports since July 30, 2015 according to SRatingsIntel. As per Thursday, February 2, the company rating was downgraded by BTIG Research. The firm has “Buy” rating given on Monday, April 4 by BTIG Research. Deutsche Bank maintained the stock with “Hold” rating in Thursday, October 26 report. The rating was maintained by Jefferies with “Buy” on Monday, April 4. The firm earned “Overweight” rating on Monday, April 11 by JP Morgan. The stock of Edwards Lifesciences Corp (NYSE:EW) has “Outperform” rating given on Wednesday, February 3 by RBC Capital Markets. JP Morgan maintained it with “Overweight” rating and $110 target in Monday, April 4 report. The stock of Edwards Lifesciences Corp (NYSE:EW) has “Buy” rating given on Tuesday, October 10 by Jefferies. The company was maintained on Tuesday, May 30 by RBC Capital Markets. Canaccord Genuity maintained it with “Buy” rating and $155.0 target in Sunday, October 8 report.

About shares traded. Invesco Dynamic Credit Opportunities Fd (VTA) has risen 13.25% since November 15, 2016 and is uptrending. It has underperformed by 3.45% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By :